Your browser doesn't support javascript.
loading
Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma.
Zhang, Tao; Su, Fei; Wang, Bofang; Liu, Lixin; Lu, Yongbin; Su, Hongxin; Ling, Ruijiang; Yue, Peng; Dai, Huanyu; Yang, Tianning; Yang, Jingru; Chen, Rui; Wu, Ruiyue; Zhu, Kaili; Zhao, Da; Hou, Xiaoming.
Affiliation
  • Zhang T; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Su F; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China. sufei19881216@163.com.
  • Wang B; The second clinical medical college of Lanzhou University, Lanzhou, Gansu, PR China.
  • Liu L; Department of Thoracic Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Lu Y; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Su H; Department of Radiotherapy, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Ling R; Department of Thoracic Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Yue P; Department of Thoracic Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Dai H; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Yang T; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Yang J; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Chen R; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
  • Wu R; The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, PR China.
  • Zhu K; The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, PR China.
  • Zhao D; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China. zhaoda@lzu.edu.cn.
  • Hou X; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China. houxiaoming19@163.com.
Oncogene ; 43(16): 1190-1202, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38409551
ABSTRACT
Protein ubiquitination is a common post-translational modification and a critical mechanism for regulating protein stability. This study aimed to explore the role and potential molecular mechanism of ubiquitin-specific peptidase 38 (USP38) in the progression of lung adenocarcinoma (LUAD). USP38 expression was significantly higher in patients with LUAD than in their counterparts, and higher USP38 expression was closely associated with a worse prognosis. USP38 silencing suppresses the proliferation of LUAD cells in vitro and impedes the tumorigenic activity of cells in xenograft mouse models in vivo. Further, we found that USP38 affected the protein stability of transcription factor Krüppel-like factors 5 (KLF5) by inhibiting its degradation. Subsequent mechanistic investigations showed that the N-terminal of USP38 (residues 1-400aa) interacted with residues 1-200aa of KLF5, thereby stabilizing the KLF5 protein by deubiquitination. Moreover, we found that PIAS1-mediated SUMOylation of USP38 was promoted, whereas SENP2-mediated de-SUMOylation of USP38 suppressed the deubiquitination effects of USP38 on KLF5. Additionally, our results demonstrated that KLF5 overexpression restored the suppression of the malignant properties of LUAD cells by USP38 knockdown. SUMOylation of USP38 enhances the deubiquitination and stability of KLF5, thereby augmenting the malignant progression of LUAD.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Adenocarcinoma of Lung Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2024 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Adenocarcinoma of Lung Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2024 Document type: Article Country of publication: United kingdom